US equity
·Updated Oct 12, 21:38 UTCCODX
Co-Diagnostics, Inc.
Health Care·Small cap·$5M
1.25
+11.6% today
No price history available for this name yet.
Returns & momentum
1D+11.6%
1W+13.6%
1M+11.6%
3M-51.4%
6M-13.8%
1Y-90.3%
YTD—
All-time—
Range & moving averages
Price1.25
52w high-97.3%
52w low+38.0%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume650.1K
Turnover$813K
Market cap$5M
RVOL2.35×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $622K | $4M | $7M | $34M | $98M | $75M | $215K | $40K | $8K | — |
| Cost of revenue | $222K | $999K | $4M | $5M | $12M | $17M | $112K | $9K | $302 | — |
| Gross profit | $400K | $3M | $3M | $29M | $86M | $58M | $103K | $31K | $7K | — |
| Research & development | $19M | $21M | $23M | $17M | $15M | $3M | $1M | $1M | $1M | $731K |
| Operating expenses | $51M | $43M | $45M | $56M | $40M | $16M | $6M | $6M | $5M | $2M |
| Operating income | -$50M | -$40M | -$43M | -$27M | $46M | $42M | -$6M | -$6M | -$5M | -$2M |
| Interest expense | — | — | — | — | — | — | $106K | — | $310K | $241K |
| Income tax | -$2M | $57K | -$3M | -$5M | $9M | $91K | — | — | — | — |
| Net income | -$47M | -$38M | -$35M | -$14M | $37M | $42M | -$6M | -$6M | -$7M | -$2M |
| EPS — basic | -$35.25 | -$37.22 | -$1.20 | -$0.45 | $1.27 | $1.59 | -$0.37 | — | — | — |
| EPS — diluted | -$35.25 | -$37.22 | -$1.20 | -$0.45 | $1.23 | $1.52 | -$0.37 | — | — | — |
| Shares — basic | 1.33M | 1.01M | 29.35M | 31.48M | 28.87M | 26.72M | 16.76M | — | — | — |
| Shares — diluted | 1.33M | 1.01M | 29.35M | 31.48M | 29.9M | 28M | 16.76M | — | — | — |
From SEC filings (public domain), since 2016. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.